Brian M. Moran

407 total citations
12 papers, 334 citations indexed

About

Brian M. Moran is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, Brian M. Moran has authored 12 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Brian M. Moran's work include Pancreatic function and diabetes (9 papers), Diabetes Treatment and Management (9 papers) and Cannabis and Cannabinoid Research (3 papers). Brian M. Moran is often cited by papers focused on Pancreatic function and diabetes (9 papers), Diabetes Treatment and Management (9 papers) and Cannabis and Cannabinoid Research (3 papers). Brian M. Moran collaborates with scholars based in United Kingdom and Ireland. Brian M. Moran's co-authors include Aine McKillop, Peter R. Flatt, Yasser H.A. Abdel‐Wahab, Finbarr O’Harte, Srividya Vasu and Anthony McCabe and has published in prestigious journals such as Diabetologia, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Brian M. Moran

12 papers receiving 333 citations

Peers

Brian M. Moran

SURGE

EDM

PHARM

CMN

Weiwen Hu China

Emma K. Biggs United Kingdom

Lisa Getty‐Kaushik United States

Susanna Mac United States

Patricio Atanes United Kingdom

Saja Baraghithy Israel

Yoshitaka Yasuhara Japan

Joshua C. Neuman United States

Yuko Muramatsu Japan

Ann-Marie Richard United States

Weiwen Hu China

Brian M. Moran

163 ×0.9

SURGE

144 ×0.9

EDM

129 ×0.9

49 ×0.5

PHARM

28 ×0.5

CMN

Citations per year, relative to Brian M. Moran Brian M. Moran (= 1×) peers Weiwen Hu

Countries citing papers authored by Brian M. Moran

Since Specialization

Citations

This map shows the geographic impact of Brian M. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Moran more than expected).

Fields of papers citing papers by Brian M. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Moran. The network helps show where Brian M. Moran may publish in the future.

Co-authorship network of co-authors of Brian M. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Moran. A scholar is included among the top collaborators of Brian M. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Moran. Brian M. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

McKillop, Aine, et al.. (2023). Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508. Life Sciences. 318. 121475–121475. 6 indexed citations

McCabe, Anthony, et al.. (2022). Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. Cancers. 14(8). 2027–2027. 4 indexed citations

Moran, Brian M., et al.. (2022). Current and Future Therapies for Pancreatic Ductal Adenocarcinoma. Cancers. 14(10). 2417–2417. 19 indexed citations

Moran, Brian M., et al.. (2019). Zinc-induced activation of GPR39 regulates glucose homeostasis through glucose-dependent insulinotropic polypeptide secretion from enteroendocrine K-cells. Biological Chemistry. 400(8). 1023–1033. 10 indexed citations

McKillop, Aine, et al.. (2018). Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion. Peptides. 100. 165–172. 20 indexed citations

Moran, Brian M., Aine McKillop, & Finbarr O’Harte. (2016). Development of novel ligands for peptide GPCRs. Current Opinion in Pharmacology. 31. 57–62. 21 indexed citations

McKillop, Aine, et al.. (2016). Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice. Diabetologia. 59(12). 2674–2685. 39 indexed citations

Moran, Brian M., Peter R. Flatt, & Aine McKillop. (2016). G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis. Acta Diabetologica. 53(2). 177–188. 41 indexed citations

Moran, Brian M., Yasser H.A. Abdel‐Wahab, Srividya Vasu, Peter R. Flatt, & Aine McKillop. (2015). GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis. Acta Diabetologica. 53(2). 279–293. 16 indexed citations

10.

Moran, Brian M., Yasser H.A. Abdel‐Wahab, Peter R. Flatt, & Aine McKillop. (2014). Evaluation of the insulin‐releasing and glucose‐lowering effects of GPR120 activation in pancreatic β ‐cells. Diabetes Obesity and Metabolism. 16(11). 1128–1139. 52 indexed citations

11.

McKillop, Aine, Brian M. Moran, Yasser H.A. Abdel‐Wahab, & Peter R. Flatt. (2013). Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta‐cells, isolated pancreatic islets and mice. British Journal of Pharmacology. 170(5). 978–990. 69 indexed citations

12.

Moran, Brian M., Yasser H.A. Abdel‐Wahab, Peter R. Flatt, & Aine McKillop. (2013). Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biological Chemistry. 395(4). 453–464. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact